«A wearable sensor called μCor, which detects fluid buildup in the lungs, can help patients with heart failure avoid readmission to hospital within 90 days, according to new data from the BMAD trial.»
» The tool is attached to the left side of a patient’s chest and assesses thoracic fluid using radiofrequency signals, as well as detecting ECG, heart rate, respiration rate, activity and posture. The study enrolled 494 patients who had experienced a heart failure event within the prior six months.»
Those who wore the device and received transmitted data were 38% less likely to be hospitalized for heart failure within 90 days.»
Article written by Caitlin E. Cox.